Fibrin Patch-Based Insulin-Like Growth Factor-1 Gene-Modified Stem Cell Transplantation Repairs Ischemic Myocardium

Jun Li,Kai Zhu,Shan Yang,Yulin Wang,Changfa Guo,Kanhua Yin,Chunsheng Wang,Hao Lai
DOI: https://doi.org/10.1177/1535370214556946
2015-01-01
Experimental Biology and Medicine
Abstract:Bone marrow mesenchymal stem cells (BMSCs), tissue-engineered cardiac patch, and therapeutic gene have all been proposed as promising therapy strategies for cardiac repair after myocardial infarction. In our study, BMSCs were modified with insulin-like growth factor-1 (IGF-1) gene, loaded into a fibrin patch, and then transplanted into a porcine model of ischemia/reperfusion (I/R) myocardium injury. The results demonstrated that IGF-1 gene overexpression could promote proliferation of endothelial cells and cardiomyocyte-like differentiation of BMSCs in vitro. Four weeks after transplantation of fibrin patch loaded with gene-modified BMSCs, IGF-1 overexpression could successfully promote angiogenesis, inhibit remodeling, increase grafted cell survival and reduce apoptosis. In conclusion, the integrated strategy, which combined fibrin patch with IGF-1 gene modified BMSCs, could promote the histological cardiac repair for a clinically relevant porcine model of I/R myocardium injury.
What problem does this paper attempt to address?